Januvia and Copegus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Januvia (sitagliptin phosphate) and Copegus (ribavirin). Common drug interactions include rash among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Januvia and Copegus. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.

What is Copegus?

Copegus has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 15,115 Copegus users. Check the latest studies of Copegus.

On Jul, 19, 2026

35 people who take Januvia and Copegus together, and have interactions are studied.

What are the common drug interactions of Januvia and Copegus, by gender? *:

female:

Rash
Vertigo
Dyspnoea (difficult or laboured respiration)
Platelet count decreased
Pyrexia (fever)
Renal failure acute (rapid kidney dysfunction)
Visual impairment
Anaemia (lack of blood)
Decreased appetite
Dehydration (dryness resulting from the removal of water)

male:

Rash
Muscular weakness (muscle weakness)
Cardiac tamponade (fluid accumulates in heart covering)
Hypoaesthesia (reduced sense of touch or sensation)
Oedema (fluid collection in tissue)
Pericardial haemorrhage (bleeding into the heart)
Pericarditis (inflammation of the pericardium)
Arthralgia (joint pain)
Decreased appetite
Depression

What are the common drug interactions of Januvia and Copegus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Muscular weakness (muscle weakness)
Hypoaesthesia (reduced sense of touch or sensation)
Rash
Arthralgia (joint pain)
Decreased appetite
Depression
Glomerulonephropathy (any noninflammatory disease of the renal glomeruli)
Leukopenia (less number of white blood cells in blood)
Myalgia (muscle pain)
Neutropenia (an abnormally low number of neutrophils)

50-59:

Blood bilirubin unconjugated increased
Gastric varices haemorrhage (dilated submucosal veins in the stomach with bleeding)
Haematemesis (vomiting of blood)
Haemoglobin decreased
Abdominal pain
Chest pain
Cough
Depression
Dizziness postural
Dyspnoea (difficult or laboured respiration)

60+:

Rash
Anaemia (lack of blood)
Oedema (fluid collection in tissue)
Pericardial haemorrhage (bleeding into the heart)
Pericarditis (inflammation of the pericardium)
Vertigo
Colon cancer
Platelet count decreased
Pyrexia (fever)
Visual impairment

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 14.29%
Type 2 Diabetes: 4 people, 11.43%

* Approximation only. Some reports may have incomplete information.

Do you take Januvia and Copegus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously